Date: 16th July, 2026
Board Meeting Outcomes
- The Company acquired 79,36,50,794 equity shares at issue price of ₹13.86 per equity share aggregating to ₹11,00,00,00,005 (₹11,000 crore) in Alkem Medtech Private Limited
- The acquisition was executed through a rights basis offering
- Shares were allotted on 15th July, 2026
Disinvestment / Strategic Actions
- Entity involved: Alkem Medtech Private Limited, a wholly owned subsidiary of the Company in India
- Nature of transaction: Rights issue subscription
- Number of shares acquired: 79,36,50,794 equity shares
- Price per share: ₹13.86
- Total consideration: ₹11,00,00,00,005 (₹11,000 crore)
- Resulting impact: Maintains 100% ownership of subsidiary
Subsidiary / Associate Update
- Alkem Medtech Private Limited background:
- Incorporated on 27th March, 2024 under Companies Act, 2013
- Engaged in medical device segment mainly in cardiovascular and orthopedic fields
- Turnover details:
- FY 2025-2026: ₹15.13 crores
- FY 2024-2025: ₹NIL
- Country of presence: India
Additional Information
- Industry classification: Medical Device
- Objects of acquisition: To maintain 100% ownership of wholly-owned subsidiary
- Consideration type: Cash consideration
- Disclosure will be made available on Company's website as per Regulation 30(8) of SEBI LODR Regulations